Word: biotechs
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...HAVE A FOCUS, TRY A NICHE SITE "There's a greater connection," says Josh Maybar, who hires for the Trust for Public Land and advertises openings on Idealist.org a site that caters to nonprofits. Jobhunt.org lists many niche sites, from Medzilla.com (for biotech and health-care workers) to Careers.findlaw.com (for lawyers). America's Job Bank, at ajb.org has links to state government job banks...
...quarterly decrease since the industry peaked in the first quarter of 2000, when $28.6 billion was invested. "It was an unhealthy level of investment in 1999 and 2000," says the National Venture Capital Association's Jeanne Metzger. "Now we've leveled off comfortably, at about $4 billion a quarter." Biotech is the main beneficiary, having received $873 million in the third quarter, unseating software and reaching the top for the first time in seven years. New money has been slow to flow into venture-capital firms, but that shouldn't hurt young companies hungry for funding. The venture capitals didn...
...It’s important to keep a sense of humor if you want office behavior to change,” said Vicky Sato ’68, president of Vertex Pharmaceuticals, a biotech company...
There's still plenty of risk. On the docket are a dozen unproven biotech firms. Money-losing companies like Anchor Glass and Red Envelope have already slipped through the IPO window. Yet even these outfits are a cut above the dogs of the '90s. The biotechs are nearing approval for new treatments. Anchor, which makes bottles for Snapple, shed pension and health-care costs in bankruptcy court. Red Envelope is an online gift store that should be profitable next quarter, says Linda Killian, a partner at the IPO research firm Renaissance Capital...
...this, he took a data set provided by Virco Group—a Belgium-based biotech company—containing both sequences of the protease genome and measurements of the amount of amprenavir necessary to inhibit replication of HIV by 50 percent for 2,747 patients...